GEORGE YANCOPOULOS - Bd. Co-Chair, President & CSO, Director at REGENERON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Bd. Co-Chair, President & CSO, Director
Issuer Symbol
REGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GEORGE YANCOPOULOS since 04 Feb 2025

Holdings reported by GEORGE YANCOPOULOS for REGENERON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 310,460 $239,703,061 $772.09 31 Dec 2025 Direct
Common Stock 200,000 $138,516,000 $692.58 31 Dec 2025 By 2025 GRAT
Common Stock 200,000 $138,516,000 $692.58 31 Dec 2025 By 2025 GRAT II
Common Stock 180,000 $124,664,400 $692.58 31 Dec 2025 By Trust for Chldn.
Common Stock 101,988 $70,634,849 $692.58 31 Dec 2025 by 2024 GRAT II
Common Stock 71,487 $49,510,466 $692.58 31 Dec 2025 By 2024 GRAT
Common Stock 56,048 $38,817,723 $692.58 31 Dec 2025 by Children
Common Stock 5,962 $4,129,161 $692.58 31 Dec 2025 By 401(k) Plan
2020 Performance Stock Units 595,077 31 Dec 2025 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 09 Dec 2025 Direct Common Stock

Transactions reported by GEORGE YANCOPOULOS for REGENERON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.